Healthcare Technology Featured Article

March 07, 2013

Tuberculosis Now Easier to Diagnose Using Nanotechnology


Nano Labs Corp. has just presented the results of its biological diagnostic tests, which it has obtained on a miniature biosensor for tuberculosis.

The nanotechnology company has used this demonstration to show that it has successfully finished a Point-of-Care biosensor, and to present the healthcare industry with its own ideas for the miniaturization and mass commercialization of these devices. The Point-of-Care system represents a revolution in medical technology by which doctors can test and diagnose conditions in their patients on the spot, meaning that the patient receives an almost immediate result and is no longer disturbed by the anxiety of waiting periods that are often seen in traditional laboratory settings. Nano Labs' proposal creates a framework for the development of more Point-of-Care (PoC) and Lab-on-a-Chip (LoC) units. The concept behind LoC is the placement of many, or all, of a laboratory's functions within a single chip, allowing for a very quick test of biological samples.

Nano Labs has proposed four solutions that would help the healthcare industry reach the goal of creating and manufacturing a simple, cheap, sensitive, and quick diagnostic platform by which doctors can be deployed to monitor and quickly get to the bottom of very common and devastating infectious diseases such as tuberculosis. The four solutions for micro-technology diagnoses are as follows: Micro Electrochemical Impedance Spectroscopy, Quantum-Dots Microchannels, Surface Acoustic Wave Micro-Electro-Mechanical-System, and Surface Plasmon Resonance Spectroscopy & Plasmonic Enzyme-Linked Immuno Sorbent Assay.

Dr. Victor Castano, the chief innovation officer at Nano Labs, said, "It is important to note that innovative, comprehensive strategies for obtaining a functional prototype will need to be carefully addressed for all projects, at any development stage. This includes packaging, interconnect with outside world, and modular integration on circuits or with some sort of display."

President of Nano Labs, Bernardo Chavarria, said, "We are looking at partnerships that bring the experience, dedication, and the vision to address critical world health issues, like tuberculosis. We expect that new research areas and biosensor solutions will emerge from this project and therefore present a much larger scope of practical applications that need to be further investigated. This technology has enormous potential and will bring exciting new opportunities to our company."




Edited by Brooke Neuman






FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]